Amiodarone-induced	amiodarone-induced	O	O	O	O
sinoatrial	sinoatrial	O	DISEASE	OTHERS	I
block	block	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
observed	observed	O	O	O	O
sinoatrial	sinoatrial	O	DISEASE	OTHERS	I
block	block	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
chronic	chronic	O	O	O	O
amiodarone	amiodarone	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
5-year-old	5-year-old	O	O	O	O
boy	boy	O	O	O	O
with	with	O	O	O	O
primary	primary	O	O	OTHERS	I
cardiomyopathy	cardiomyopathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
Wolff-Parkinson-White	wolff-parkinson-white	O	O	O	O
syndrome	syndrome	O	O	O	O
and	and	O	O	O	O
supraventricular	supraventricular	O	O	OTHERS	I
tachycardia	tachycardia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Reduction	reduction	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
dosage	dosage	O	O	O	O
of	of	O	O	O	O
amiodarone	amiodarone	CHEMICALS	O	OTHERS	I
resulted	resulted	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
disappearance	disappearance	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
sinoatrial	sinoatrial	O	DISEASE	OTHERS	I
block	block	O	DISEASE	OTHERS	I
and	and	O	O	O	O
the	the	O	O	O	O
persistence	persistence	O	O	O	O
of	of	O	O	O	O
asymptomatic	asymptomatic	O	O	O	O
sinus	sinus	O	DISEASE	OTHERS	I
bradycardia	bradycardia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

